Literature DB >> 26011715

The wedding cake solution: A percutaneous correction of a form fruste superior sinus venosus atrial septal defect.

Matthew A Crystal1, Julie A Vincent1, William A Gray2.   

Abstract

We present the case of a patient with a superior sinus venosus defect (SSVD), with the atypical finding of an intact atrial septum and posterior atrial wall, which underwent percutaneous closure in the cardiac catheterization laboratory for repair. SSVDs are rare congenital cardiac anomalies, but when the anatomy is amenable to percutaneous strategies, a collaborative and creative approach can result in a safe and effective result.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  covered stent; percutaneous; sinus venosus defect

Mesh:

Year:  2015        PMID: 26011715     DOI: 10.1002/ccd.26031

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  Unanticipated complication of transcatheter correction of superior sinus venosus atrial septal defect.

Authors:  Radhapriya Yalamanchi; Muthukumaran C Sivaprakasam; Raja Vijendra Reddy Janke; Krishnaswamy Chandrasekharan; Vijay Shankar Sadhasivam; Refai Showkathali
Journal:  J Cardiol Cases       Date:  2021-08-09

Review 2.  Hemodynamic assessment of atrial septal defects.

Authors:  Alejandro Javier Torres
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 3.  Building an Adult Congenital Heart Program: Critical Components and Important Allies.

Authors:  Akanksha Thakkar; Stephanie Fuentes-Rojas; Eunice Karanja; Ebun Ebunlomo; Allison Millette; Christine H Lee; Y Serena Shen-Lin; Gary Monteiro; Thomas MacGillivray; C Huie Lin
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

4.  Transcatheter closure of a sinus venosus atrial septal defect using 3D printing and image fusion guidance.

Authors:  Akanksha N Thakkar; Ponraj Chinnadurai; John P Breinholt; C Huie Lin
Journal:  Catheter Cardiovasc Interv       Date:  2018-06-13       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.